Glenn Schulman | Investor Relations |
Peter Greenleaf | Chief Executive Officer |
Dennis Bourgeault | Chief Financial Officer |
Neil Solomons | Chief Medical Officer |
Michael Martin | Chief Operating Officer |
Alethia Young | Cantor Fitzgerald |
Joseph Schwartz | SVP Leerink |
Ed Arce | H.C. Wainwright |
Justin Kim | Oppenheimer & Company |
Greetings, and welcome to the Aurinia Pharmaceuticals Third Quarter 2019 Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.
It’s now my pleasure to introduce your host, Glenn Schulman.